Testing hypotheses about the relationship between cannabis use and psychosis

Drug and Alcohol Dependence

Volumn 71, Issue 1, 2003, Pages 37-48

  Degenhardt, Louisa ^a   Hall, Wayne ^a   Lynskey, Michael ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cannabis use; Psychosis; Schizophrenia

Indexed keywords

CANNABIS;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AUSTRALIA; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG USE; FEMALE; HUMAN; HYPOTHESIS; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; TIME;

CANNABIS;

EID: 0038042275     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00064-4     Document Type: Article

References (72)

1. Allebeck P., Adamsson C., Engstrom A., Rydberg U. Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County [published erratum appears in Acta Psychiatr. Scand. 1993 Oct; 88 (4) 304]. Acta Psychiatr. Scand. 88:1993;21-24.
2. Andreasson S., Allebeck P. Cannabis and mortality among young men: a longitudinal study of Swedish conscripts. Scand. J. Soc. Med. 18:1990;9-15.
3. Andreasson S., Allebeck P., Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet. 2:1987;1483-1486.
4. Anthony J.C., Helzer J. Syndromes of drug abuse and dependence. Robins L.N., Regier D.A. Psychiatric Disorders in America. 1991;116-154 The Free Press, New York.
5. Bamrah J., Freeman H., Goldberg D. Epidemiology of schizophrenia in Salford, 1974-84: changes in an urban community over 10 years. Br. J. Psychiatry. 159:1992;802-810.
6. Basu D., Malhotra A., Bhagat A., Varma V.K. Cannabis psychosis and acute schizophrenia - a case-control study from India. Eur. Addict. Res. 5:(2):1999;71-73.
7. Batel P. Addiction and schizophrenia. Eur. Psychiatry. 15:(2):2000;115-122.
8. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometr. Bull. 2:1946;47-53.
9. Bernardson G., Gunne L.M. Forty-six cases of psychosis in cannabis abusers. Int. J. Addict. 7:1972;9-16.
10. Blanchard J., Brown S., Horan W., Sherwood A. Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin. Psychol. Rev. 20:(2):2000;207-234.
11. Brewin J., Cantwell R., Dalkin T., Fox R., Medley I., Glazebrook C., Kwiecinski R., Harrison G. Incidence of schizophrenia in Nottingham: a comparison of two cohorts, 1978-1980 and 1992-1994. Br. J. Psychiatry. 171:(8):1997;140-144.
12. Brown S. Excess mortality of schizophrenia. A meta-analysis. Br. J. Psychiatry. 171:1997;502-508.
13. Carney M.W.P., Bacelle L., Robinson B. Psychosis after cannabis use. Br. Med. J. 288:1984;1047.
14. Caron C., Rutter M. Comorbidity in child psychopathology: concepts, issues and research strategies. J. Child. Psychol. Psychiatry. 32:(2):1991;1063-1080.
15. Carone B., Harrow M., Westermeyer J. Posthospital course and outcome in schizophrenia. Arch. Gen. Psychiatry. 48:1991;247-253.
16. Castle D., Wesseley S., Der G., Murray R. The incidence of operationally defined schizophrenia in Camberwell, 1965-84. Br. J. Psychiatry. 159:1991;790-794.
17. Chen K., Kandel D.B. The natural history of drug use from adolescence to the mid-thirties in a general population sample [see comments]. Am. J. Public Health. 85:(1):1995;41-47.
18. Chopra G.S., Smith J.W. Psychotic reactions following cannabis use in East Indians. Arch. Gen. Psychiatry. 30:1974;24-27.
19. Cuffel B.J., Heithoff K.A., Lawson W. Correlates of patterns of substance abuse among patients with schizophrenia. Hospital Community Psychiatry. 44:1993;247-251.
20. Degenhardt L., Hall W. The association between psychosis and problematical drug use among Australian adults: Findings from the National Survey of Mental Health and Well-Being. Psychol. Med. 31:(4):2001;659-668.
21. Degenhardt L., Lynskey M., Hall W. Cohort trends in the age of initiation of drug use in Australia. Aust. N. Z. J. Public Health. 24:(4):2000;421-426.
22. DiMaggio C., Martinez M., Menard J.-F., Petit M., Thibaut F. Evidence of a cohort effect for age at onset of schizohprenia. Am. J. Psychiatry. 158:(3):2001;489-492.
23. Donnelly N., Hall W. Patterns of cannabis use in Australia. NCADA Monograph Series No. 27. 1994;Australian Government Publishing Service, Canberra.
24. Eagles J. Is schizophrenia disappearing? Br. J. Psychiatry. 158:1991;834-835.
25. Eagles J., Whalley L. Decline in the diagnosis of schizophrenia among first admissions to Scottish mental hospitals from 1969 to 1978. Br. J. Psychiatry. 146:1985;151-154.
26. Eaton W.W., Mortensen P.B., Herrman H., Freeman H., Bilker W., Burgess P., Wooff K. Long-term course of hospitalization for schizophrenia: Part I. Risk for rehospitalization. Schizophr. Bull. 18:(2):1992;217-228.
27. Eaton W.W., Mortensen P.B., Herrman H., Freeman H., Bilker W., Burgess P., Wooff K. Long-term course of hospitalization for schizophrenia: Part II. Change with passage of time. Schizophr. Bull. 18:(2):1992;229-240.
28. Eva J. Cannabis psychosis. Psychiatr. Bull. 16:1992;310-311.
29. Fowler I., Carr V., Carter N., Lewin T. Patterns of current and lifetime substance use in schizophrenia. Schizophr. Bull. 24:(3):1998;443-455.
30. Galbaud Du Fort G., Newman S., Bland R. Psychiatric comorbidity and treatment seeking: sources of selection bias in the study of clinical populations. J. Nerv. Ment. Dis. 181:(8):1993;464-474.
31. Geddes J., Black R., Whalley L., Eagles J. Persistence of the decline in the diagnosis of schizophrenia among first admissions to Scottish hospitals from 1969 to 1988. Br. J. Psychiatry. 163:1993;620-626.
32. Goldstein G., Hall W., Andrews G. The incidence of schizophrenia in New South Wales, Australia. Acta Psychiatr. Scand. 70:1984;220-227.
33. Gruber A.J., Pope H.G. Cannabis psychotic disorder: does it exist? Am. J. Addict. 3:1994;72-83.
34. Gut-Fayand A., Dervaux A., Olie J.-P., et al. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry. Res. 102:2001;65-72.
35. Haefner H. Epidemiology of schizophrenia. Haefner H., Gattaz W., Janzarik W. Search for the Causes of Schizophrenia. 1987;Springer-Verlag, Berlin.
36. Haefner H., an der Heiden W. The contribution of European case registers to research on schizophrenia. Schizophr. Bull. 12:1986;26-51.
37. Hall W. Cannabis use and psychosis. Drug Alcohol Rev. 17:1998;433-444.
38. Hall W., Degenhardt L. Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust. N. Z. J. Psychiatry. 34:2000;26-34.
39. Hall W., Swift W. The THC content of cannabis in Australia: evidence and implications. Aust. N. Z. J. Public Health. 24:2000;503-508.
40. Hall W., Goldstein G., Andrews G., Lapsley H., Bartels R., Silove D. Estimating the economic costs of schizophrenia. Schizophr. Bull. 11:1985;598-611.
41. Hall W., Teesson M., Lynskey M., Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-Being. Addiction. 94:(10):1999;1541-1550.
42. Hambrecht M., Haefner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective. Aust. N. Z. J. Psychiatry. 34:2000;468-475.
43. Harrison G., Cooper J., Gancarczyk R. Changes in the administrative incidence of schizophrenia. Br. J. Psychiatry. 159:1991;811-816.
44. Jablensky A., McGrath J., Herrman H., Castle D., Gureje O., Evans M., Carr V., Morgan V., Korten A., Harvey C. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence disorders. Aust. N. Z. J. Psychiatry. 43:2000;221-236.
45. Jablensky, A., Sartorius, N., Ernberg, G., 1991. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization Ten-Country Study. Psychological Medicins Supplement No. 20.
46. Jones P., Cannon M. The new epidemiology of schizophrenia. Psychiatr. Clin. North Am. 21:(1):1998;1-25.
47. Joyce P. Changing trends in first admissions and readmissions for mania and schizophrenia in New Zealand, 1974-1984. Aust. N. Z. J. Psychiatry. 21:1987;82-86.
48. Kendell R., Malcolm D., Adams W. The problem of detecting changes in the incidence of schizophrenia. Br. J. Psychiatry. 162:1993;212-218.
49. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch. Gen. Psychiatry. 51:1994;273-279.
50. Makkai T., McAllister I. Patterns of drug use in Australia, 1985-1995. 1998;Australian Government Publishing Service, Canberra.
51. Mason P., Harrison G., Glazebrook C., Medley I., Croudace T. The course of schizophrenia over 13 years. A report from the International Study on Schizophrenia (ISoS) coordinated by the World Health Organization. Br. J. Psychiatry. 169:(5):1996;580-586.
52. Mathers D., Ghodse A., Caan A., Scott S. Cannabis use in a large sample of acute psychiatric admissions. Br. J. Addict. 86:1991;779-784.
53. McCoy A. Drug Traffic: Narcotics and Organised Crime in Australia. 1980;Harper and Row, Sydney.
54. McGuire P., Jones R., Harvey I., Williams M., McGuffin P., Murray R. Morbid risk of schizophrenia for relatives of patients with cannabis associated psychosis. Schizophr. Res. 15:1995;277-281.
55. McKay D.R., Tennant C.C. Is the grass greener? The link between cannabis and psychosis. Med. J. Aust. 172:(6):2000;284-286.
56. Mueser K., Yarmnold P., Levinson D., Singh H., Bellack A., Kee K., Morrison R., Yadalam K. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr. Bull. 16:1990;31-56.
57. Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict. Behav. 23:(6):1998;717-734.
58. Munk-Jorgensen P. Decreasing rates of incident schizophrenia cases in psychiatric services: a review of the literature. Eur. Psychiatry. 10:1995;129-141.
59. Munk-Jorgensen P., Mortensen P. Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-1987. Br. J. Psychiatry. 161:1992;489-495.
60. Parker G., O'Donnell M., Walter S. Changes in the diagnoses of the functional psychoses associated with the introduction of lithium. Br. J. Psychiatry. 146:1985;377-382.
61. Robins, L.N., Regier, D.A. (Eds.), 1991. Psychiatric disorders in America: The Epidemiological Catchment Area study. New York: The Free Press.
62. Rolfe M., Tang M., Sabally S., Todd J., Sam E., Hatib N'Jie A. Psychosis and cannabis abuse in the Gambia: a case-control study. Br. J. Psychiatry. 163:1993;798-801.
63. Rosenthal R. Is schizophrenia addiction prone? Curr. Opin. Psychiatry. 11:1998;45-48.
64. Sidney S., Beck J.E., Tekawa I.S., Quesenberry C.P. Jr, Friedman G.D. Marijuana use and mortality. Am. J. Public Health. 87:(4):1997;585-590.
65. Solomons K., Neppe V.M., Kuyl J.M. Toxic cannabis psychosis is a valid entity. S. Afr. Med. J. 78:1990;476-481.
66. Suvisaari J., Haukka J., Tanskanen A., Lonnqvist J. Decline in the incidence of schizophrenia in Finnish birth cohorts born from 1954 to 1965. Arch. Gen. Psychiatry. 56:1999;733-740.
67. Takei N., Lewis G., Sham P., Murray R. Age-period-cohort analysis of the incidence of schizophrenia in Scotland. Psychol. Med. 26:1996;963-973.
68. Tennant F.S., Groesbeck C.J. Psychiatric effects of hashish. Arch. Gen. Psychiatry. 27:1972;133-136.
69. Thornicroft G. Cannabis and psychosis: is there epidemiological evidence for an association? Br. J. Psychiatry. 157:1990;25-33.
70. Tien A.Y., Anthony J.C. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J. Nerv. Ment. Dis. 178:(8):1990;473-480.
71. Wylie A.S., Scott R.T.A., Burnett S.J. Psychosis due to 'skunk'. Br. Med. J. 311:1995;125.
72. Ziedonis D., Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr. Bull. 23:1997;229-238.